Diamond Hill Capital Management’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-217,003
| Closed | -$5.7M | – | 175 |
|
|
2022
Q1 | $5.7M | Sell |
217,003
-64,167
| -23% | -$1.57M | 0.02% | 131 |
|
|
2021
Q4 | $6.67M | Sell |
281,170
-70,657
| -20% | -$1.74M | 0.02% | 129 |
|
|
2021
Q3 | $8.82M | Hold |
351,827
| – | – | 0.03% | 124 |
|
|
2021
Q2 | $9.14M | Sell |
351,827
-90,610
| -20% | -$2.47M | 0.03% | 124 |
|
|
2021
Q1 | $11.3M | Sell |
442,437
-2,427
| -0.5% | -$62.2K | 0.05% | 123 |
|
|
2020
Q4 | $8.91M | Buy |
444,864
+2,306
| +0.5% | +$45.2K | 0.04% | 124 |
|
|
2020
Q3 | $7.58M | Buy |
442,558
+58,647
| +15% | +$1.11M | 0.04% | 120 |
|
|
2020
Q2 | $8.38M | Buy |
383,911
+111,830
| +41% | +$2.56M | 0.05% | 119 |
|
|
2020
Q1 | $6.29M | Sell |
272,081
-101,214
| -27% | -$2.94M | 0.04% | 120 |
|
|
2019
Q4 | $12.3M | Buy |
373,295
+6,819
| +2% | +$219K | 0.06% | 115 |
|
|
2019
Q3 | $11.7M | Sell |
366,476
-25,091
| -6% | -$731K | 0.06% | 113 |
|
|
2019
Q2 | $10.1M | Buy |
391,567
+2,509
| +0.6% | +$63.9K | 0.05% | 120 |
|
|
2019
Q1 | $9.87M | Sell |
389,058
-46,035
| -11% | -$1.37M | 0.05% | 122 |
|
|
2018
Q4 | $14.8M | Sell |
435,093
-72,568
| -14% | -$2.36M | 0.09% | 116 |
|
|
2018
Q3 | $18.1M | Sell |
507,661
-566
| -0.1% | -$20K | 0.09% | 112 |
|
|
2018
Q2 | $17.5M | Sell |
508,227
-1,727
| -0.3% | -$60.5K | 0.09% | 110 |
|
|
2018
Q1 | $17.2M | Sell |
509,954
-410
| -0.1% | -$13K | 0.09% | 108 |
|
|
2017
Q4 | $19.5M | Sell |
510,364
-18,260
| -3% | -$729K | 0.1% | 111 |
|
|
2017
Q3 | $19.8M | Sell |
528,624
-16,525
| -3% | -$583K | 0.1% | 111 |
|
|
2017
Q2 | $20.3M | Sell |
545,149
-30,445
| -5% | -$1.1M | 0.11% | 113 |
|
|
2017
Q1 | $22.6M | Sell |
575,594
-13,957
| -2% | -$524K | 0.13% | 110 |
|
|
2016
Q4 | $20.5M | Sell |
589,551
-193
| -0% | -$7.58K | 0.12% | 114 |
|
|
2016
Q3 | $23.2M | Sell |
589,744
-1,512
| -0.3% | -$60.3K | 0.14% | 111 |
|
|
2016
Q2 | $22.3M | Hold |
591,256
| – | – | 0.14% | 107 |
|
|
2016
Q1 | $22.7M | Buy |
591,256
+100,625
| +21% | +$3.75M | 0.14% | 102 |
|
|
2015
Q4 | $23.6M | Sell |
490,631
-467,675
| -49% | -$21.6M | 0.16% | 102 |
|
|
2015
Q3 | $37.8M | Buy |
958,306
+79,986
| +9% | +$3.4M | 0.26% | 80 |
|
|
2015
Q2 | $37.4M | Sell |
878,320
-3,480
| -0.4% | -$139K | 0.25% | 81 |
|
|
2015
Q1 | $34.8M | Sell |
881,800
-54,068
| -6% | -$1.99M | 0.24% | 84 |
|
|
2014
Q4 | $33.7M | Sell |
935,868
-24,602
| -3% | -$826K | 0.24% | 75 |
|
|
2014
Q3 | $28.3M | Sell |
960,470
-9,160
| -0.9% | -$253K | 0.22% | 83 |
|
|
2014
Q2 | $24.4M | Buy |
969,630
+1,280
| +0.1% | +$31.6K | 0.19% | 82 |
|
|
2014
Q1 | $25M | Sell |
968,350
-4,950
| -0.5% | -$125K | 0.21% | 79 |
|
|
2013
Q4 | $21.9M | Sell |
973,300
-33,480
| -3% | -$647K | 0.2% | 84 |
|
|
2013
Q3 | $14.3M | Buy |
1,006,780
+940,250
| +1,413% | +$12.6M | 0.14% | 96 |
|
|
2013
Q2 | $908K | Buy |
+66,530
| New | +$907K | 0.01% | 136 |
|
Other funds holding NTUS
MAM
Diamond Hill Capital Management's NTUS Position: Q2 2022 in Review
Diamond Hill Capital Management sold out of Natus Medical Inc (NTUS) in Q2 2022, closing a stake of 217,003 shares — an estimated $5.7M sold.
Diamond Hill Capital Management first reported a position in NTUS in Q2 2013 and held it in 36 quarters. The position peaked at $37.8M in Q3 2015. 186 funds tracked by Wall St. Rank hold NTUS as of Q2 2022.
- Diamond Hill Capital Management reported no remaining Natus Medical Inc position as of Q2 2022 after selling out during the quarter.
- Diamond Hill Capital Management sold 217,003 Natus Medical Inc shares in Q2 2022, an estimated $5.7M.
- Diamond Hill Capital Management first reported a position in Natus Medical Inc in Q2 2013 and held it in 36 quarters.
- Diamond Hill Capital Management's Natus Medical Inc position peaked at $37.8M in Q3 2015.
- 186 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2022.
Based on Diamond Hill Capital Management's 13F filing for Q2 2022, filed 9 Aug 2022.